The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts

Serra Ucer1, Srividhya Iyer1, Shoshana M Bartell1

  • 1Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System, Little Rock, AR, USA.

Insights

Androgen receptor signaling in osteoblasts is crucial for maintaining cancellous bone mass in male mice. However, androgens affect cortical bone through indirect mechanisms, not directly via androgen or estrogen receptor signaling in bone cells.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Genetics

Background:

  • Androgens are vital for bone health in men, influencing both cortical and cancellous bone.
  • Previous studies linked androgen receptor (AR) deletion in mature osteoblasts/osteocytes to reduced cancellous bone mass.
  • The role of AR and estrogen receptor alpha (ERα) in osteoprogenitors and osteoclasts, and the impact of testosterone aromatization to estradiol, remained unclear for cortical bone.

Purpose of the Study:

  • To elucidate the specific cell lineages mediating androgen's effects on cortical and cancellous bone.
  • To differentiate between direct AR signaling and indirect mechanisms, including ERα pathways, in bone maintenance.
  • To determine the necessity of AR and ERα in mesenchymal and myeloid cells for bone homeostasis.

Main Methods:

  • Generated genetically modified mice with targeted deletion of AR or ERα in mesenchymal (Prx1-Cre) or myeloid (LysM-Cre) lineages.
  • Utilized Osterix-Cre (Osx1-Cre) to target osteoprogenitors.
  • Assessed bone phenotypes at baseline and after orchidectomy (ORX) to model androgen deprivation.

Main Results:

  • AR deletion in mesenchymal progenitors (AR(f/y);Prx1-Cre) mimicked orchidectomy effects on cancellous bone, reducing bone volume and trabecular number while increasing osteoclast number.
  • Deletion of AR in myeloid cells or ERα in mesenchymal/myeloid cells did not affect baseline cancellous bone or ORX-induced loss.
  • Unexpectedly, all four genetic models showed no baseline cortical bone phenotype and identical cortical bone loss post-ORX, indicating AR/ERα independence in these lineages for cortical bone.

Conclusions:

  • Androgen's effects on cancellous bone are mediated by AR signaling specifically within osteoblasts, independent of osteoclasts or aromatization.
  • Androgens do not appear to regulate cortical bone mass directly through AR or ERα signaling in osteoblast or osteoclast precursors.
  • Cortical bone regulation by androgens likely involves indirect mechanisms acting on non-skeletal cell types or tissues.